化合物 Cangrelor free acid T70335
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 163706-06-7 | ¥15,300.00 | 询底价 |
25 mg | 163706-06-7 | ¥11,700.00 | 询底价 |
100 mg | 163706-06-7 | ¥19,500.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Cangrelor free acid
描述: Cangrelor is a P2Y12 inhibitor, and was approved in June 2015 as an antiplatelet drug for intravenous application. Cangrelor is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggregate. It is a modified ATP derivative stable to enzymatic degradation. It does not require metabolic conversion to an active metabolite. This allows cangrelor’s immediate effect after infusion, and the therapeutic effects can be maintained with continuous infusion.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: NSC 147831 | Cangrelor free acid | NSC-147831 | NSC147831
化合物 Cangrelor free acid T70335信息由TargetMol中国为您提供,如您想了解更多关于化合物 Cangrelor free acid T70335报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途